Trial intelligence / Profile preview

Perioperative intravenous amiodarone to prevent new-onset atrial fibrillation after CABG

ChiCTR2100054587Phase 4Recruiting

Sponsor
Fuwai Hospital
Start
Nov 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of amiodarone in Atrial fibrillation (AFib) (2 arms), sponsored by Fuwai Hospital. Primary endpoint: Incidence of new-onset atrial fibrillation. Started Nov 2020; status: recruiting.

02

Drugs

amiodarone
03

Conditions

Atrial fibrillation (AFib)

Beyond the preview

Go deeper on ChiCTR2100054587.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100054587.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call